It was all smiles at the White House in 2017 when executives from Corning Incorporated visited President Trump’s administration to unveil an innovative new pharmaceutical vial. As part of the White House’s “Made in America” initiative, Corning brought a sample of its Valor Glass container, which was developed with Pfizer and Merck, and had become the first new pharma glass composition approved by the U.S. Food and Drug Administration in over 100 years. To demonstrate Valor Glass’ durability — one of its prime advantages over traditional borosilicate glass — Corning’s CEO, Wendell Weeks, asked the president to break a conventional vial by pressing down on it with a lever. In one quick pop, the borosilicate vial was shattered. While some glass companies are optimistic that they will be able to meet the demand being generated by the coronavirus while keeping up with existing commitments, others admit that the market for glass vials could be in shortage for many months to come. How can the glass industry keep its supply lines from cracking under the weight of COVID-19? Click Here For Complete Article Text
|
|||||||||||||||||||||||||||
| Application Sequencing | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | ||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||